TerrAscend (TSNDF) Gains from Investment Securities (2020 - 2025)
TerrAscend (TSNDF) reported Gains from Investment Securities of -$6.8 million for Q4 2025, up 20.31% year-over-year from -$5.7 million in Q4 2024, and down 1209.17% quarter-over-quarter from $616049.0 in Q3 2025.
TerrAscend (TSNDF) Gains from Investment Securities (2020 - 2025) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Gains from Investment Securities data on file, last reported at -$6.8 million in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at -$6.8 million, up 20.31% year-over-year; the trailing twelve-month figure through Dec 2025 was -$13.6 million (down 154.25% YoY), and the FY2025 annual result was $13.9 million, up 467.72% from the prior year.
- Gains from Investment Securities eased to -$6.8 million in Q4 2025 per TSNDF's latest filing, from $616049.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $17.5 million in Q2 2023 and troughed at -$10.2 million in Q4 2022.
- A 5-year average of $272089.6 and a median of $173098.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities tumbled 840.74% in 2022, then surged 51427.55% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at $1.4 million in 2021, then plunged by 840.74% to -$10.2 million in 2022, then soared by 100.07% to $7000.0 in 2023, then sank by 122600.0% to -$8.6 million in 2024, then grew by 20.31% to -$6.8 million in 2025.
- Business Quant data shows TSNDF's Gains from Investment Securities at -$6.8 million in Q4 2025, $616049.0 in Q3 2025, and -$34000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.83 Mn |
| Dec 31, 2025 | -6.83 Mn |
| Sep 30, 2025 | 616,049.00 |
| Sep 30, 2025 | 616,049.00 |
| Jun 30, 2025 | -34,000.00 |
| Jun 30, 2025 | -34,000.00 |
| Mar 31, 2025 | 158,196.00 |
| Mar 31, 2025 | 158,196.00 |
| Dec 31, 2024 | -8.58 Mn |
| Dec 31, 2024 | -8.58 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 17.52 Mn |
| Jun 30, 2023 | 17.52 Mn |